MONDAY, May 20 (HealthDay News) -- The older vaccine for
whooping cough that was phased out in the late 1990s is more
effective than the current version of the vaccine, a new study
Teenagers who received four shots with the older vaccine --
called whole-cell vaccine -- before they were 2 years old were
significantly less likely to become infected with whooping cough
during a recent outbreak in California, compared to children who
received all of their immunizations with the new vaccines, called
the acellular vaccine.
"Teens who were vaccinated with the acellular vaccine appear to have a six times higher risk of [whooping cough] than teens who received four doses of the whole-cell vaccine. And, the teens who received some whole-cell vaccine and some acellular had about a four times higher risk than teens who received all whole-cell vaccines," said the study's lead author, Dr. Nicola Klein, co-director of the Northern California Kaiser Permanente Vaccine Study Center, in Oakland.
Whooping cough, which is also known as pertussis, is a highly
contagious respiratory infection. In 2012, the United States had
the highest number of whooping cough cases since 1959 with more
than 41,000 infections and 18 deaths. Most of the deaths occurred
among infants, according to the U.S. Centers for Disease Control
The whole-cell vaccine was used from the 1940s to the 1990s, but
was phased out due to potential side effects. "The reason we
switched away from the whole-cell vaccine was that there were some
safety concerns, such as high fevers," Klein explained.
The acellular vaccine was introduced in the 1990s, and has few
side effects. However, in recent years, a number of studies have
found that the newer vaccine doesn't seem to work for as long as
the older vaccine.
California experienced an outbreak of whooping cough in 2010 and
2011. This gave researchers the chance to see how effective the
acellular vaccine was compared to the whole-cell vaccine in teens
who may have received all of their shots with one or the other
vaccine, or possibly with both.
The study included teens born from 1994 to 1999 who got their
initial four shots of whooping cough vaccine before they were 2
years old at Kaiser Permanente Northern California.
Of the study participants, 138 teens had confirmed whooping
cough. They were compared to 899 teens who'd had a lab test that
confirmed they didn't have whooping cough, and to 54,339 "matched
The researchers found that the fewer number of whole-cell
vaccines a teen had received, the greater the risk of whooping
Teens who had received all acellular vaccines had a 5.63 times
greater risk of whooping cough than teens who'd gotten all
whole-cell vaccines. Teens who received both acellular and
whole-cell vaccines had a 3.77 times higher risk of whooping cough
compared to those who had all whole-cell vaccines.
"The whole-cell vaccine may stimulate the immune response more, but there were a lot of safety concerns with that vaccine. We're really thinking the way forward is to develop a new vaccine," said Klein. But, she added, "Right now, make sure your children receive all their vaccines and boosters on schedule. This [acellular] vaccine does work, just not for as long as we would've hoped."
Dr. Kenneth Bromberg, director of the Vaccine Research Center
and chairman of pediatrics at The Brooklyn Hospital Center in New
York City, agreed that there's no going back to the whole-cell
vaccine because of its side effects. "It's a moot point. We don't
have whole-cell vaccine anymore," he said.
"The acellular vaccine doesn't last as long as the whole-cell vaccine, but it's not like it doesn't work. It does," he said. "And, it's a vaccine that's had almost all of the side effects removed."
Bromberg said it's important to make sure that those who are
most vulnerable are protected, and in the case of whooping cough
that's usually infants.
"Newborns and babies in the first few months of life are the most likely to die from pertussis," he said. "That's why the CDC recommends that pregnant women get the acellular vaccine in the last trimester of pregnancy. It will give their babies antibodies to protect them when they're most vulnerable."
Results of the study were released online May 20 in
Pediatricsand will appear in the June print issue of the
Learn more about whooping cough and the pertussis vaccine from
U.S. Centers for Disease Control and
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.